United States · FDA National Drug Code directory
Zanaflex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70515-602_3468e009-cfd1-f217-e063-6294a90a1429
- Product NDC
- 70515-602
- Form
- CAPSULE
- Composition / generic term
- tizanidine hydrochloride
- Labeler
- Covis Pharma US, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180801
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 150 CAPSULE in 1 BOTTLE (70515-602-15) · 70515-602-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →